Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection [Phase 3]
Phase 3 trial evaluating whether olmesartan medoxomil benefits the cardiovascular system by arterial protection in metabolic syndrome and hy…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment [Phase 3]
A Phase 3 study evaluating CS-3150 in combination with an ARB or ACE inhibitor for hypertension in patients with moderate renal impairment h…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Patients With Severe Hypertension [Phase 3]
Phase 3 clinical trial update for CS-3150 in patients with severe hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Study of CS-3150 in Hypertensive Patients With Type 2 Diabetes and Albuminuria [Phase 3]
A Phase 3 clinical trial evaluating CS-3150 in hypertensive patients with type 2 diabetes and albuminuria has completed.
-
FDA approval · 2018-12-19FDA Approved: METOPROLOL SUCCINATE — Original Application (Oryza Pharmaceuticals, Inc)
The FDA approved Oryza Pharmaceuticals' generic metoprolol succinate product, an extended-release beta-blocker used to treat hypertension, a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Perioperative Blood Pressures and Chronic Hypertension
Clinical trial update on perioperative blood pressures in individuals with chronic hypertension; results completed with posted results in 20…
-
FDA approval · 2018-12-13FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for irbesartan from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins [Phase 2]
Phase 2 trial update evaluating QGC001 in hypertensive overweight patients of multiple ethnic origins has completed.
-
FDA approval · 2018-12-07FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approval of AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE for the Original Application (ANDA) by Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Nebivolol and the Endothelin (ET)-1 System [Phase 4]
Phase 4 trial update investigating nebivolol and the endothelin-1 system in prehypertension and hypertension; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety [Phase 4]
Phase 4 trial update comparing tandospirone, amlodipine, and their combination in adults with hypertension and anxiety.
-
FDA approval · 2018-12-04FDA Approved: CANDESARTAN CILEXETIL — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for candesartan cilexetil from Alembic Pharmaceuticals Limited, enabling a generic version of the anti…
-
FDA approval · 2018-12-03FDA Approved: AMLODIPINE AND OLMESARTAN MEDOXOMIL — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved the original application for a generic fixed-dose combination of amlodipine and olmesartan medoxomil for hypertension. The prod…
-
CLINICAL_TRIALS trial_result · 2018-11-21Clinical Trial Update: Combined Rg3-enriched Korean Red Ginseng and American Ginseng in the Management of Hypertension in Type 2 Diabetes [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating combined Rg3-enriched Korean Red Ginseng and American Ginseng for managing hypertension in individuals w…
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial comparing short-term effects of perindopril-amlodipine versus perindopril-indapamide in patients with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Health Effects of Increasing Muscle Activation While Sitting in Office Workers [NA]
A completed clinical trial investigating the health effects of increasing muscle activation while sitting in office workers, focusing on blo…
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)
A long-term (12-month) special surveillance trial of candesartan cilexetil/hydrochlorothiazide combination tablets in hypertension has compl…
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients [Phase 4]
A Phase 4 clinical trial evaluating the effects of nebivolol on skeletal muscle performance during exercise in patients with hypertension ha…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Renal Denervation for Resistant Hypertension [Phase 4]
Phase 4 clinical trial update for renal denervation in resistant hypertension; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」
Clinical trial update for candesartan cilexetil under a special drug use surveillance program; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of MK-8266 in Elderly Participants With High Blood Pressure (MK-8266-003) [Phase 1]
Phase 1 trial assessing safety, tolerability, and pharmacokinetics of MK-8266 in elderly individuals with hypertension; study completed with…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Aldosterone Antagonism and Microvascular Function [Phase 4]
Phase 4 clinical trial update on aldosterone antagonism evaluating microvascular function in abdominal obesity/metabolic syndrome with insul…
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Renal Denervation for Complicated Hypertension [Phase 4]
Phase 4 clinical trial update for renal denervation in complicated hypertension has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-11-05Clinical Trial Update: Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD) [Phase 4]
A Phase 4 clinical trial update on nighttime losartan in continuous ambulatory peritoneal dialysis for patients with hypertension and nephro…
-
FDA approval · 2018-11-02FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for IRBESARTAN by Hisun Pharmaceuticals USA Inc. The approval indicates changes related to the a…